Compliance and persistence with treatment with parathyroid hormone for osteoporosis. A Danish national register-based cohort study

The mortality and direct medical costs of osteoporotic fractures among postmenopausal women in Taiwan

(2015) C.-Y. Chang et al.   OSTEOPOROSIS INTERNATIONAL

Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS)

(2014) Ö. Ljunggren et al.   CURRENT MEDICAL RESEARCH AND OPINION

Differences in persistency with teriparatide in patients with osteoporosis according to gender and health care provider

(2014) I. Kyvernitakis et al.   OSTEOPOROSIS INTERNATIONAL

Use of Recombinant Human Parathyroid Hormone(1–84) in Patients with Postmenopausal Osteoporosis

(2013) Rüdiger Möricke et al.   CLINICAL DRUG INVESTIGATION

Treatment persistence and changes in fracture risk, back pain, and quality of life amongst patients treated with teriparatide in routine clinical care in France: Results from the European Forsteo Observational Study

(2013) Gerald Rajzbaum et al.   JOINT BONE SPINE

Persistence and compliance of medications used in the treatment of osteoporosis – analysis using a large scale, representative, longitudinal German database

(2012) Volker Ziller et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Adherence and persistence in patients with severe osteoporosis treated with teriparatide

(2010) V. Ziller et al.   CURRENT MEDICAL RESEARCH AND OPINION

Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance

(2010) S. A. Foster et al.   OSTEOPOROSIS INTERNATIONAL

Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)

(2009) Bente L. Langdahl et al.   CALCIFIED TISSUE INTERNATIONAL

Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden

(2008) Ström Oskar et al.   Acta Orthopaedica

Persistence with teriparatide in postmenopausal osteoporosis; impact of a patient education and follow-up program: the French experience

(2008) K. Briot et al.   OSTEOPOROSIS INTERNATIONAL

Medication Compliance and Persistence: Terminology and Definitions

(2007) Joyce A. Cramer et al.   VALUE IN HEALTH